KDR and cancer: For example a tri-therapy currently under trial targets PDGFR (expressed by cancer cells, MSCs and fibroblasts), VEGFR (expressed by endothelial cells as well as cancer cells) and FGFR (expressed by fibroblasts and cancer cells).